Khan, Kamran. 2025. “Efficacy and Safety of Sitagliptin, Metformin and Pioglitazone Fixed-Dose Combination Therapy (100 mg/1000mg and 15 Mg Respectively) As a First-Line Treatment in Obese Type 2 Diabetes With High Insulin Resistance”. International Journal of Medical and Biomedical Studies 9 (1):247-51. https://doi.org/10.32553/ijmbs.v9i1.3064.